SH-SY5Y cells as a model for sigma receptor regulation of potassium-stimulated dopamine release

被引:22
作者
Ault, DT
Werling, LL
机构
[1] George Washington Univ, Med Ctr, Program Neurosci, Washington, DC 20037 USA
[2] George Washington Univ, Med Ctr, Dept Pharmacol, Washington, DC 20037 USA
关键词
SH-SY5Y; sigma receptor; NPY; dopamine; (+)-pentazocine;
D O I
10.1016/S0006-8993(00)02722-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Previous studies in our laboratory using rat brain tissue have shown that neuropeptide Y (NPY) can enhance NMDA- and potassium-stimulated dopamine release from various brain regions and that this enhancement is reversed by sigma (sigma) receptor antagonists. In the current study, we sought to determine whether SN-SY5Y cells are suitable for investigating sigma receptor effects and whether any a receptors present are of the subtype responsive to NPY. We compare mechanisms by which the prototypical sigma receptor agonist (+)-pentazocine, and the proposed endogenous a receptor ligand NPY regulate potassium-stimulated [H-3]dopamine release from SH-SY5Y cells. Both (+)-pentazocine and NPY inhibit potassium-stimulated [H-3]dopamine release. Unlike our studies in rat brain tissue, the effect of NPY on [H-3]dopamine release is not reversed by sigma receptor antagonists. SH-SY5Y cells appear to be an appropriate model to study the regulation of dopamine release by sigma receptors or by NPY receptors, but this population is not identical to that population identified in brain slices. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:354 / 360
页数:7
相关论文
共 28 条
[1]  
Ault DT, 1998, J PHARMACOL EXP THER, V284, P553
[2]   Phencyclidine and dizocilpine modulate dopamine release from rat nucleus accumbens via σ receptors [J].
Ault, DT ;
Werling, LL .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 386 (2-3) :145-153
[3]   Neuropeptide Y mediated enhancement of NMDA-stimulated [3H]dopamine release from rat prefrontal cortex is reversed by σ1 receptor antagonists [J].
Ault, DT ;
Werling, LL .
SCHIZOPHRENIA RESEARCH, 1998, 31 (01) :27-36
[4]   Differential modulation of NMDA-stimulated [H-3]dopamine release from rat striatum by neuropeptide Y and sigma receptor ligands [J].
Ault, DT ;
Werling, LL .
BRAIN RESEARCH, 1997, 760 (1-2) :210-217
[5]  
Cassarino DS, 1998, J NEUROCHEM, V71, P295
[6]   Neuropeptide Y Y-2 receptor and somatostatin sst(2) receptor coupling to mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells [J].
Connor, M ;
Yeo, A ;
Henderson, G .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 120 (03) :455-463
[7]   delta- and mu-Opioid receptor mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells [J].
Connor, M ;
Henderson, G .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 117 (02) :333-340
[8]   COMPARISON OF CYTOTOXICITY OF A QUATERNARY PYRIDINIUM METABOLITE OF HALOPERIDOL (HP+) WITH NEUROTOXIN N-METHYL-4-PHENYLPYRIDINIUM (MPP(+)) TOWARDS CULTURED DOPAMINERGIC NEUROBLASTOMA-CELLS [J].
FANG, J ;
ZUO, D ;
YU, PH .
PSYCHOPHARMACOLOGY, 1995, 121 (03) :373-378
[9]  
GONZALEZALVEAR GM, 1994, J PHARMACOL EXP THER, V271, P212
[10]  
Hong W., 1999, Society for Neuroscience Abstracts, V25, P1475